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Abstract: The ERBE BiClamp® BVSS appears to be a safe and effective method of vaginal hysterectomy in this small single 
surgeon, single institution study; demonstrating efficient operative times, minimal blood loss and intraoperative morbidity 
with acceptable surgical outcomes. Its use contributes to the advancement of minimally invasive gynaecology and should be 
encouraged.
INTRODUCTION
Approximately 50,000 hysterectomies are performed 
annually in the UK1.  With fewer complications and a quicker 
recovery, the vaginal route is preferred over its abdominal 
counterpart2. This is endorsed in the National Institute of 
Clinical Excellence (NICE) guidelines on heavy menstrual 
bleeding and a 34-study Cochrane review2,3. The American 
Association of Gynecologic Laparoscopists (AAGL) 
highlight that hysterectomy for benign uterine disease 
should be performed either vaginally or laparoscopically4. 
This affirms the American College of Obstetricians and 
Gynaecologists’ (ACOG) statement that the vaginal approach 
should be primary whenever feasible due to better patient 
outcomes and fewer complications than laparoscopic or 
abdominal surgery5. AAGL have recently launched an online 
master course in vaginal hysterectomy (VH) to support this6.
VH yields a speedier return to normal activity, fewer febrile 
episodes, shorter hospital admission, shorter operative time 
and less blood loss4,7. Despite this, there is a reluctance 
towards VH due to the challenging surgical technique with 
limited access to deep vascular pedicles making haemostasis 
and suture ligation potentially problematic8. Bipolar vessel 
sealing systems (BVSS) are proven to be safe and efficacious 
with possible advantages over conventional methods, namely 
less post-operative pain, reduced blood loss, shorter operative 
time and hospital stay9-16.
The ERBE BiClamp® BVSS are insulated forceps with an 
automatic coagulation completion. The technique has similar 
anatomical principles to conventional methods, shortening 
the learning curve. It requires only two instruments; easing 
access and reducing trauma risk. Initial studies into VH 
using BiClamp® suggest that patients experience less post-
operative pain and shorter operative duration17. Coagulation 
effects on innervation of the surgical field and the need for 
less downward traction on the uterus may explain improved 
post-operative pain tolerance15. These effects also prevent 
“back-bleeding”, ensuring better haemostasis and reducing 
surgical field visual impairment. We investigated the use of 
ERBE BiClamp® BVSS in VH in terms of safety and efficacy 
with possible advantages over conventional suture ligation, 
namely less post-operative pain, reduced blood loss, shorter 
operative time and hospital stay.
MATERIALS AND METHODS
The setting was a major district general hospital in Northern 
Ireland where a single surgeon began using the ERBE 
BiClamp® BVSS for VH in 2006, following a period of 
training with a recognised expert, Dr Henri Clavé in Nice, 
France.  
We conducted a retrospective case review of all VH 
performed using the ERBE BiClamp® BVSS over a 7-year 
period (September 2006 – May 2014). Exclusion criteria 
were: VH performed by other surgeons within the same time 
period or using conventional suture ligation.
Details of surgical technique and device
The technique is a variation of the classical form of VH 
using electro-surgery via the ERBE Vio® generator and 
the Bi-Clamp® forceps to achieve haemostasis. Following 
circumferential cervical incision, the anterior and posterior 
pouches are carefully opened to gain access to the peritoneal 
cavity. The Bi-Clamp® forceps are then used to sacrifice the 
pelvic floor ligamentous support and the uterine vascular 
pedicles before being transected with curved mayo scissors. 
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The salient part of the operation is the amputation of the 
cervix after coagulation of the uterine arteries allowing 
uterine rotation, not traction. This is imperative in haemostasis 
and negates the need for uterine prolapse. Vaginal bilateral 
salphingoophrectomy (BSO) is also possible. The vaginal 
vault is closed with a continuous dissolvable suture with an 
effort to incorporate the anterior and posterior leaves of the 
pelvic parietal peritoneum. 
Outcome measures
Data collected included patient demographics, type of 
procedure and indication, including additional vaginal or 
laparoscopic BSO or pelvic floor repair (PFR). 
Primary outcome measures included:
• Operating time: from knife to skin until closure of the 
vaginal vault. 
• Peri-operative blood loss: determined by haemoglobin 
(Hb) drop between pre-operative and post-operative 
values (g/dL).
• Complication rate: Intraoperative, short-term, within 
2 post-operative weeks and long-term complications, 
indicated through outpatient review and re-referral 
patterns. 
• Post-operative analgesia requirements: determined by 
analgesia consumption during post-operative hospital 
admission, as an average dose per day.
• Length of hospital stay: in post-operative days.
RESULTS
A total of 200 patients were included over a 7 year period. 
(See Figure 1)
Median age was 51 years (range: 24–83). Median Body Mass 
Index (BMI) was 28.5kg/m2 (Interquartile range (IQR) 9.75), 
based upon 60.5% of patients as this was unobtainable in the 
remainder. BMI was greater than 35kg/m2 in 23% of patients. 
Regional anaesthesia only was used in 4% of cases.
Median parity was 2 (IQR 2) with 19.5% of patients being 
nulliparous. Obstetric history was known in 70% of patients, 
of whom 7% had caesarean sections. Data on previous surgery 
was available in 70% of patients. Of these, 50% had had no 
previous pelvic surgery, with the commonest previous surgery 
being laparoscopic sterilization (11.5%). 5% of patients had 
underwent a previous laparotomy. Indications for VH are 
detailed in Table 1. VH alone occurred in 56% of patients 
with 44% having additional procedures; laparoscopic BSO 
(28.5%), vaginal BSO (13.5%), PFR (2%). Laparoscopic 
BSO was only conducted if vaginal BSO was unsuccessful 
or not feasible.
Operating time
Median operating time for VH (+/- BSO or PFR) was 47 
minutes (IQR 9, Mean 49.72+/-15.07, 95% Cl 47.21-52.23). 
83% of VH alone were <60 minutes. Median operating 
time for VH and Laparoscopic BSO was 75 minutes (IQR 
27, Mean 75.65+/-20.31, 95% CI 70.16–80.14). 64% of 
all operations were <60 minutes. Operating time was not 
recorded in 2% of cases.
Peri-operative blood loss 
Median Hb drop was 1.2g/dL (IQR 0.9, Mean 1.128+/-0.833, 
95% Cl 0.952–1.305), based upon 44% of patients as 48.5% 
did not have a post-operative Hb measurement and in 7.5% 
results were unobtainable.
Complications
93% of cases had no major intraoperative complications. 
The commonest complication was bladder injury (2.5%), but 
this wasn’t associated with long term sequelae. In 2 cases, 
this was not due the BiClamp® forceps and occurred during 
dissection of the anterior fornix. There were no incidents of 
No.	vaginal	hysterectomies	
perfomed	 by	single	
surgeon	within	time	frame	
Sept06	- May14
(n	=234	)
No.	vaginal	hysterectomies	
performed	 using	ERBE	
BiClamp®	 BVSS
(n	=	214)
No.	cases	not	included*
(n	=	14)
No.	cases	included	 in	data	
collection
(n	=	200)	
No.	vaginal	hysterectomies	
not	performed	 using	ERBE	
BiClamp®	 BVSS
(n=	20)
Pateints	excluded	from	
study	
(n=	20)
Fig 1. Formation of the study cohort
*Cases not included due to notes being unobtainable.
Table 1: 
Indications for surgery
Indication for surgery % of patients
Benign
Menorrhagia/failed conservative management 23.9
Cervical intra-epithelial neoplasia (CIN) 11.7
Endometriosis / Chronic Pelvic Pain 7.8
Uterovaginal Prolapse 6.3
Endometrial Hyperplasia 4.8
Other benign indications 3.4
Malignant
Endometrial carcinoma 36.5
Cervical Carcinoma 5.3
*Other indications for surgery included prophylactic 
(HNPCC/BRCA carrier or family history of carcinoma), 12 
week sized fibroid, previous vulval angiomyxoma.
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bowel injury, labial or vaginal burns. Additional haemostatic 
sutures to pedicles were required in 4.5% of operations. 
Abdominal/laparoscopic conversion rate was 2%, due to 
bleeding with no subsequent long term complications. 2% 
of patients underwent conversion to laparotomy, all of 
whom had a BMI >35kg/m2. Indications for conversion to 
laparotomy included bleeding (1.5%) and poor laparoscopic 
views (0.5%).  In one case, ureteric injury resulted in anuria 
and acute nephropathy due to bilateral distal ureteric kinking 
with partial obstruction, secondary to vaginal vault closure. 
This necessitated ureteric stenting (which was removed six 
months following surgery) and bilateral nephrostomies. After 
follow-up, the patient was discharged with no long term 
complications. An American Society of Anaesthesiologists 
(ASA) physical status classification of >1 occurred in 
65% of patients (of the 70% in which ASA was recorded), 
highlighting the extent of co-morbidity within our population. 
Consequently, in this high-risk group, anaesthetic problems, 
namely atrial fibrillation, asystole, which recovered, and chest 
pain occurred in 1.5% of cases.
Return to theatre occurred in 2.5%, indications being; 
bleeding, haematoma evacuation and ureteric injury. Vault 
haematoma occurred in 2.5% of patients with 1% returning 
to theatre. Two patients required transfusion of packed 
red blood cells, in accordance with UK Blood Transfusion 
Advisory Committee Guidelines18. Both patients returned 
to theatre on the first post-operative day due to bleeding. 
Urinary retention requiring an indwelling catheter on 
hospital discharge occurred in 2% of patients, none of whom 
experienced voiding dysfunction beyond 2 post-operative 
weeks. Direct microscopy-confirmed urinary tract infection 
(UTI) rate was 4%. Hospital readmission occurred in 2% of 
patients, indications being urosepsis, vault haematoma, post-
operative ileus, and constipation. There were no recorded 
cases of venous thromboembolism or death related to surgery. 
Long term follow up was conducted through telephone 
calls, outpatient review or re-referral and involved physical 
examination if warranted. 4% of patients were lost to follow 
up and duration ranged from 6 months-5 years. There were no 
long-term complications reported in 97% of cases. Prolapse 
requiring further surgery occurred in 1% of cases and 
persistent pelvic pain in 2% of cases, 50% of which pelvic 
pain and endometriosis were the initial indication for surgery. 
Post-operative analgesia requirements 
Simple analgesia was required by 76.5% of patients 
(Paracetamol, Codeine Phosphate or Non-steroidal anti-
inflammatories). The average number of doses per day of 
Paracetamol (1g) or Codeine Phosphate (60mg) was 2.58 and 
of non-steroidal anti-inflammatory drugs (Sodium Diclofenac 
75mg) was 0.8. 2.5% of patients received Tramadol and one 
patient received hyoscine butylbromide.
Opioid analgesia consumption occurred in 23.5% of patients, 
at an average of 0.98 doses per day (range 0.14–3.75) (1 dose 
= 5mg Morphine Sulphate). A patient-controlled analgesia 
system was used by 2% of patients, 75% of whom underwent 
conversion to laparotomy returned to theatre.
Length of hospital stay
37% of patients were discharged on the first post-operative 
day and 89% were discharged within 3 days. Median length 
of stay was 2 days (IQR 2, Mean 2.13+/-1.34, 95% Cl 
1.94–2.32). 79.5% of patients were admitted the night before 
surgery, to ensure bed availability, however length of hospital 
stay was measured in post-operative days. 10.5% of patients 
were admitted on the day of surgery and discharged on the 
first post-operative day.
DISCUSSION
This retrospective case review suggests that ERBE 
BiClamp® BVSS is a safe and effective alternative to its 
conventional counterpart in VH. Intraoperative morbidity 
was minimal, 83% of VH alone were less than 60 minutes, 
median haemoglobin drop was 1.2g/dL, post-operative stay 
was 2 days and 76.5% of patients required simple analgesia 
only. The commonest intraoperative complication was 
bladder injury (2.5%), resulting in no long-term morbidity. 
Bleeding requiring laparotomy/laparoscopy and conversion 
to laparotomy both occurred in 2% of patients. UTI was the 
commonest short-term complication (4%). 97% of patients 
reported no long term complications. 
This study of BiClamp® BVSS is, to our knowledge, the 
largest conducted by a single surgeon, in a single institution. 
We note an improvement in operator performance with time, 
with only one intraoperative complication (conversion to 
laparotomy due to bleeding and difficult access in a patient 
with a BMI of 47kg/m2) occurring in the last 16 months of 
data collection. One strength of our study is that high BMI 
wasn’t an exclusion criterion, with 23% of patients having a 
known BMI >35kg/m2. Intraoperative complication rate in 
patients with BMI <35kg/m2 compared to BMI >35kg/m2 was 
5.4% and 11% respectively. This result is limited as BMI data 
was obtained for only 60.5% of the cohort. Caesarean section 
also wasn’t a contra-indication, with 7% of patients having 
had at least one previous caesarean. This did not increase the 
intraoperative complication rate. 
Our study was a retrospective, single surgeon, single 
institution study so it is difficult to know how this will 
translate into wider clinical practice. Data collection was 
based on review of medical records and may not have been 
complete. Peri-operative blood loss data, for example, 
was based upon 44% of the cohort, mainly because post-
operative Hb measurements are not routine. In our institution, 
intraoperative surgical protocol dictates that all patients 
have a pre-operative Hb measurement. If this is low or 
estimated blood loss is significant, a post-operative Hb is 
measured. Prospective data collection would allow blood 
loss estimation through counting and weighing of surgical 
swabs. Furthermore, weight and size of uterine specimens 
was unobtainable. Secondly, post-operative pain was 
determined by analgesia consumption, however prospective 
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data collection may have permitted the use of pain intensity 
scores. Thirdly, as a control group was not included, this study 
is not a direct comparison to conventional methods of VH. A 
prospective randomised control trial (RCT) however, would 
allow for direct comparison. Our results have therefore, been 
compared with other published evidence, as detailed below. 
A recent meta-analysis, incorporating eight RCTs, on 
electrosurgical bipolar vessel sealing (EBVS) for VH 
included 772 patients, with 2 studies, pooling 118 cases, 
reporting BiClamp® usage19-21. Main outcomes included 
operative duration, intraoperative blood loss, complication 
rate and hospital stay19. We report similar results to those 
outlined. A shorter operating time with EBVS over suture 
ligation is reported by all studies. Estimated blood loss in 
our study wasn’t comparable as blood loss wasn’t calculated 
in millilitres, however Pergialiotis et al. conclude that the 
mean difference in blood loss between EBVS and suture 
ligation was statistically significant (p<0.001)19. Ghirardini 
et al. report similar findings to our results with ∆Hb of 
1.4g/dl in their 500-case BiClamp® VH study22. They also 
present similar results regarding surgery duration (mean 48.9 
minutes) and hospital stay (mean 3.2 days)22
We report an intraoperative complication rate of 3% 
(6/200) which, whilst not statistically significant, is less 
than conventional suture ligation (OR = 0.5216 (95% CI 
– 0.1987-1.3693) p= 0.1863 Z= 1.322) and better than the 
meta-analysis EBVS / suture ligation comparison (OR = 
0.9560 (95% CI – 0.452-2.0222) p= 0.9063 Z= 0.118). (See 
Figure 2)19 19Similar findings are noted in the individual 
intra-operative complication rates with our data approaching 
statistical significance and displaying better P values than the 
EBVS/suture ligation comparison. (See Figure 3) Specifically, 
our rate is lower than the BiClamp® VH subgroup (3.3%, 
1/30) and is over six times the size20. We report no labial burns 
and one case of ureteric injury, a complication not recorded 
in the meta-analysis. 
A19 2% major post-operative complication rate, which 
is lower than the meta-analysis suture ligation is close to 
statistical significance (OR = 0.3697 (95% CI – 0.1226-
1.1151) p= 0.0773 Z= 1.767. This is  again less than 
both EBVS and suture ligation  (OR = 0.5863 (95% CI – 
0.2643-1.3009) p= 0.1892 Z= 1.313). (See Figures 4 and 5) 
Pergialiotis et al. conclude that EBVS systems, in comparison 
to traditional suture ligation, lead to a statistically significant 
decrease in intraoperative blood loss but don’t shorten 
operative duration or influence complication rate19. It is 
however, important to note that interpretation is limited by 
small numbers of BiClamp® VH.
We conclude that VH using BiClamp® does not compromise 
patient safety. Safe surgical technique is paramount, 
particularly in electro surgery, and can be promoted through 
training. The technique closely mimics classical VH, making 
the learning curve achievable. It is a safe, effective, easier 
alternative to conventional suture ligation; particularly in 
the absence of uterine descent or a narrow vaginal introitus. 
Notably, 19.5% of our patients were nulliparous and BMI was 
>35kg/m2 in 23%. The Northern Ireland population is very 
stable and highly amenable to follow up, facilitating close 
monitoring for long-term complications for up to seven years.
CONCLUSION
This study, to our knowledge, is the largest conducted in 
a single institution by a single surgeon. It suggests that 
ERBE BiClamp® BVSS as a safe, effective alternative to 
conventional suture ligation in VH, compared with previously 
published outcomes. The technique affords quicker operative 
times, less blood loss, minimal intraoperative morbidity and 
acceptable surgical outcomes. The reduced post-operative 
pain observed confers more rapid mobilisation and improved 
recovery. A prospective RCT would be recommended.
Modern medical practice demands clinicians to consider 
minimally invasive surgical options which are, at the very 
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Fig 3. Intraoperative complication rates of each group in 
comparison (Data from Pergialiotis et al. 2014)20 EBVS: 5.364 
(2.933-9) Suture Ligation: 5.597 (3.133-9.231) BiClamp: 3 
(1.101-6.53) EBVS v Suture p= 0.91 BiClamp vs Suture p= 0.18
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Fig 4. Major post-operative complications each group in 
comparison. (Data from Pergialiotis et al. 2014)20 EBVS: 3.135 
(1.503-5.765) Suture: 5.231 (3.047-8.375) BiClamp: 2 (0.545-
5.14) EBVS v Suture Sup= 0.19 BiClamp vs Suture  p= 0.07
	
	
	
Figure	1:	Formation	of	study	cohort	
*Cases	not	included	due	to	notes	being	unobtainable.		
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Fig 2. Intraoperative complications forest plot: our findings 
in comparison to the meta-analysis. (Data from Pergialiotis 
et al. 2014)20
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least, equal to their conventional counterparts. Our results 
suggest BiClamp® can achieve this. The procedure closely 
mimics the classical performance of VH, reducing the 
learning curve in mastering the technique and allowing the 
general gynaecologist to perform VH with improved ease 
and safety. BiClamp® BVSS appears to be an ideal platform 
to allow the replacement of the trans-abdominal route of 
hysterectomy with the preferred minimally invasive vaginal 
approach. 
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Figure	 5:	Major	 post-operative	 forest	 plot:	 our	 findings	 in	 comparison	 to	 the	meta-analysis.	 (Data	
from	Pergialiotis	et	al.	2014)20		
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